Dr. Pham-Huy completed her medical training at the University of Ottawa in 2003 and her pediatrics and infectious diseases training at McGill University in 2008. She also pursued additional training in clinical immunology. She joined CHEO in 2009, where she is the physician lead for the CHEO Primary Immunodeficiency Clinic and Program Director for the Pediatric Infectious Diseases Training Program. She is the site investigator for the Special Immunization Clinic Network from the Canadian Immunization Research Network (CIRN) and actively sees patients with adverse events following immunizations or relative contraindications to immunization. She is a member of the National Advisory Committee on Immunization (NACI) and current chair for Immunize Canada. Her research interests include the study of T cell immunity in COVID-19 infection, evaluation and management of inborn errors of immunity, immunization safety and practices, especially in special populations such as immunocompromised patients and infants exposed to biologics in utero.
Other Areas of Research: Immunizations and vaccines, Clinical Immunology
The use and impact of monoclonal antibody biologics during pregnancy
More biologics with broader indications are now available for clinical use, making it challenging to keep up with each drug’s characteristics and effects on the immune system.